Transforming growth factor-β1 in congenital ureteropelvic junction obstruction: diagnosis and follow-up

OBJECTIVE: To assess the role of transforming growth factor-β1 (TGF-β1) in congenital ureteropelvic junction obstruction at diagnosis and during postoperative follow-up. MATERIAL AND METHODS: We conducted a case-control study including 19 patients with a mean age of 6.7 years and 1...

Full description

Bibliographic Details
Main Authors: Cristian Sager, Juan C. Lopez, Victor Duran, Carol Burek, Ernesto Perazzo
Format: Article
Language:English
Published: Sociedade Brasileira de Urologia 2009-06-01
Series:International Brazilian Journal of Urology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382009000300008
_version_ 1818316991242436608
author Cristian Sager
Juan C. Lopez
Victor Duran
Carol Burek
Ernesto Perazzo
author_facet Cristian Sager
Juan C. Lopez
Victor Duran
Carol Burek
Ernesto Perazzo
author_sort Cristian Sager
collection DOAJ
description OBJECTIVE: To assess the role of transforming growth factor-β1 (TGF-β1) in congenital ureteropelvic junction obstruction at diagnosis and during postoperative follow-up. MATERIAL AND METHODS: We conducted a case-control study including 19 patients with a mean age of 6.7 years and 19 matched controls. All patients presented negative voiding cystourethrography, obstructive diuretic renogram and underwent dismembered pyeloplasty. Urinary TGF-β1 and other markers were measured pre-, intra- and postoperatively. RESULTS: The mean bladder urine TGF-β1 concentration in obstructed patients prior to pyeloplasty was higher than in controls (92.5 pg/mL ± 16.8 vs. 35.8 pg/mL ± 16.2; p = 0.0001). The mean renal pelvic urine TGF-β1 concentration in the hydronephrotic kidney was higher than in the preoperative bladder urine sample (122.3 pg/mL ± 43.9 vs. 92.5 pg/mL ± 16.8; p = 0.036). Postoperative mean TGF-β1 concentration was significantly lower than preoperative TGF-β1 (48.7 pg/mL ± 13.1 vs. 92.5 pg/mL ± 16.8; p = 0.0001). CONCLUSION: TGF-β1 is a cytokine leading to renal fibrosis. The measurement of urinary TGF-β1 could become a useful tool for the diagnosis of obstructive hydronephrosis and the evaluation of the parenchyma function status, pre and postoperatively.
first_indexed 2024-12-13T09:30:13Z
format Article
id doaj.art-5091dd33744f4412a2fcd3b9994607a0
institution Directory Open Access Journal
issn 1677-5538
1677-6119
language English
last_indexed 2024-12-13T09:30:13Z
publishDate 2009-06-01
publisher Sociedade Brasileira de Urologia
record_format Article
series International Brazilian Journal of Urology
spelling doaj.art-5091dd33744f4412a2fcd3b9994607a02022-12-21T23:52:30ZengSociedade Brasileira de UrologiaInternational Brazilian Journal of Urology1677-55381677-61192009-06-0135331532510.1590/S1677-55382009000300008Transforming growth factor-β1 in congenital ureteropelvic junction obstruction: diagnosis and follow-upCristian SagerJuan C. LopezVictor DuranCarol BurekErnesto PerazzoOBJECTIVE: To assess the role of transforming growth factor-β1 (TGF-β1) in congenital ureteropelvic junction obstruction at diagnosis and during postoperative follow-up. MATERIAL AND METHODS: We conducted a case-control study including 19 patients with a mean age of 6.7 years and 19 matched controls. All patients presented negative voiding cystourethrography, obstructive diuretic renogram and underwent dismembered pyeloplasty. Urinary TGF-β1 and other markers were measured pre-, intra- and postoperatively. RESULTS: The mean bladder urine TGF-β1 concentration in obstructed patients prior to pyeloplasty was higher than in controls (92.5 pg/mL ± 16.8 vs. 35.8 pg/mL ± 16.2; p = 0.0001). The mean renal pelvic urine TGF-β1 concentration in the hydronephrotic kidney was higher than in the preoperative bladder urine sample (122.3 pg/mL ± 43.9 vs. 92.5 pg/mL ± 16.8; p = 0.036). Postoperative mean TGF-β1 concentration was significantly lower than preoperative TGF-β1 (48.7 pg/mL ± 13.1 vs. 92.5 pg/mL ± 16.8; p = 0.0001). CONCLUSION: TGF-β1 is a cytokine leading to renal fibrosis. The measurement of urinary TGF-β1 could become a useful tool for the diagnosis of obstructive hydronephrosis and the evaluation of the parenchyma function status, pre and postoperatively.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382009000300008kidney pelviscongenital abnormalitiesUPJhydronephrosistransforming growth factor beta-1
spellingShingle Cristian Sager
Juan C. Lopez
Victor Duran
Carol Burek
Ernesto Perazzo
Transforming growth factor-β1 in congenital ureteropelvic junction obstruction: diagnosis and follow-up
International Brazilian Journal of Urology
kidney pelvis
congenital abnormalities
UPJ
hydronephrosis
transforming growth factor beta-1
title Transforming growth factor-β1 in congenital ureteropelvic junction obstruction: diagnosis and follow-up
title_full Transforming growth factor-β1 in congenital ureteropelvic junction obstruction: diagnosis and follow-up
title_fullStr Transforming growth factor-β1 in congenital ureteropelvic junction obstruction: diagnosis and follow-up
title_full_unstemmed Transforming growth factor-β1 in congenital ureteropelvic junction obstruction: diagnosis and follow-up
title_short Transforming growth factor-β1 in congenital ureteropelvic junction obstruction: diagnosis and follow-up
title_sort transforming growth factor 946 1 in congenital ureteropelvic junction obstruction diagnosis and follow up
topic kidney pelvis
congenital abnormalities
UPJ
hydronephrosis
transforming growth factor beta-1
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382009000300008
work_keys_str_mv AT cristiansager transforminggrowthfactor9461incongenitalureteropelvicjunctionobstructiondiagnosisandfollowup
AT juanclopez transforminggrowthfactor9461incongenitalureteropelvicjunctionobstructiondiagnosisandfollowup
AT victorduran transforminggrowthfactor9461incongenitalureteropelvicjunctionobstructiondiagnosisandfollowup
AT carolburek transforminggrowthfactor9461incongenitalureteropelvicjunctionobstructiondiagnosisandfollowup
AT ernestoperazzo transforminggrowthfactor9461incongenitalureteropelvicjunctionobstructiondiagnosisandfollowup